Beijing-based biotechnology firm Berry Genomics Co., Limited has completed RMB100 million (US$16 million) series B financing from Qiming Venture Partners, according to Chinese media reports. Founded in 2010, Berry Genomics received undisclosed series A financing from Legend Capital in 2011. Berry Genomics focuses on developing DNA sequencing technology and genetic testing tools for disease screening […]

Visit for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network